Giusti, V., & Suter, M. (2005). Chirurgie bariatrique : principes et techniques. *Revue Médicale Suisse*, 1(14), 894-898.
Keren, D., Rainis, T., & Lavy, A. (2014). Sleeve gastrectomy, une intervention efficace mais non dénuée de complications. *Obesite*, 9(3), 220-227.
Müller-Stich, B. P., & Fischer, L. (2015). Traitement chirurgical de l'obésité : techniques et résultats. *Der Chirurg*, 86(2), 119-127.
Cummings, D. E., & Cohen, R. V. (2016). L'émergence des analogues du GLP-1 dans le traitement de l'obésité et du diabète après une chirurgie bariatrique. *Nature Reviews Endocrinology*, 12(8), 458-467.
Bray, G. A., & Ryan, D. H. (2014). Pharmacological treatment of the overweight patient. *Endocrine Practice*, 20(4), 337-348.
Gagner, M., Deitel, M., Erickson, A. L., & Crosby, R. D. (2013). Survey on laparoscopic sleeve gastrectomy (LSG) at the Fourth International Consensus Summit on Sleeve Gastrectomy. *Obesity Surgery*, 23(12), 2013-2017.
Melissas, J., Daskalakis, M., Koukouraki, S., Askoxylakis, I., Metaxari, M., Dimitriadis, E., ... & Papadakis, J. A. (2008). Sleeve gastrectomy—a "food limiting" operation. *Obesity Surgery*, 18(10), 1251-1256.
Langer, F. B., Reza Hoda, M. A., Bohdjalian, A., Felberbauer, F. X., Zacherl, J., Wenzl, E., ... & Prager, G. (2005). Sleeve gastrectomy and gastric banding: effects on plasma ghrelin levels. *Obesity Surgery*, 15(7), 1024-1029.
Peterli, R., Wölnerhanssen, B., Peters, T., Devaux, N., Kern, B., Christoffel-Courtin, C., ... & Beglinger, C. (2009). Improvement in glucose metabolism after bariatric surgery: comparison of laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy: a prospective randomized trial. *Annals of Surgery*, 250(2), 234-241.
Himpens, J., Dobbeleir, J., & Peeters, G. (2010). Long-term results of laparoscopic sleeve gastrectomy for obesity. *Annals of Surgery*, 252(2), 319-324. :
Drucker, D. J. (2018). Mechanisms of action and therapeutic application of glucagon-like peptide-1. *Cell Metabolism*, 27(4), 740-756.
Hassanein, M., Abdallah, K., & Schweizer, A. (2014). Liraglutide 3.0 mg in combination with sleeve gastrectomy: A case series from a prospective, observational study. *Diabetes Research and Clinical Practice*, 106(3), e67-e70.
Segal-Lieberman, G., Segal, P., & Dicker, D. (2003). Orlistat: its role in the management of obesity. *Expert Opinion on Pharmacotherapy*, 4(7), 1141-1152.
Garvey, W. T., Ryan, D. H., Look, M., Gadde, K. M., Allison, D. B., Peterson, C. A., ... & Bowden, C. H. (2012). Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study. *The American Journal of Clinical Nutrition*, 95(2), 297-308.
Zuckerman, A., Finch, M., & Cooper, J. (2014). Metformin use after bariatric surgery: a matched case-control study. *Journal of Obesity & Weight Loss Therapy*, 4(4), 218.
Pi-Sunyer, X., Astrup, A., Fujioka, K., Greenway, F., Halpern, A., Krempf, M., ... & SCALE Obesity and Prediabetes NN8022-1839 Study Group (2015). A randomized, controlled trial of 3.0 mg of liraglutide in weight management. *New England Journal of Medicine*, 373(1), 11-22.
Ramos-Molina, B., Pérez-Belmonte, L. M., García-Pérez, A. M., Fernández-Carrión, R., Sánchez-Alcoholado, L., Tinahones, F. J., & Moreno-Indias, I. (2021). Effect of liraglutide on weight regain after sleeve gastrectomy: A clinical and experimental approach. *Obesity Surgery*, 31(10), 4343-4351.
Chou, J. J., Lee, W. J., Almalki, O., Chen, J. C., Tsai, P. L., & Yang, S. H. (2017). Efficacy and safety of orlistat in obese patients with type 2 diabetes after sleeve gastrectomy: a matched case-control study. *Surgical Obesity and Related Diseases*, 13(12), 1999-2009.
Boido, A., Ceriani, V., Cetta, F., Lombardi, F., & Pontiroli, A. E. (2015). Bariatric surgery and prevention of cardiovascular events and mortality in morbid obesity: mechanisms of action and choice of surgery. *Nutrition, Metabolism and Cardiovascular Diseases*, 25(5), 437-443.
De Hollanda, A., Ruiz, T., Jiménez, A., Flores, L., Lacy, A., & Vidal, J. (2015). Patterns of weight loss response following gastric bypass and sleeve gastrectomy. *Obesity Surgery*, 25(7), 1177-1183.
Yumuk, V., Tsigos, C., Fried, M., Schindler, K., Busetto, L., Micic, D., ... & Obesity Management Task Force of the European Association for the Study of Obesity (2015). European guidelines for obesity management in adults. *Obesity Facts*, 8(6), 402-424.
Frías, J. P., Davies, M. J., Rosenstock, J., Pérez Manghi, F. C., Fernández Landó, L., Bergman, B. K., ... & SURPASS-2 Investigators (2021). Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes. *New England Journal of Medicine*, 385(6), 503-515.
Müller, T. D., Blüher, M., Tschöp, M. H., & DiMarchi, R. D. (2022). Anti-obesity drug discovery: advances and challenges. *Nature Reviews Drug Discovery*, 21(3), 201-223.
Busetto, L., Dicker, D., Azran, C., Batterham, R. L., Farpour-Lambert, N., Fried, M., ... & Yumuk, V. (2017). Practical recommendations of the obesity management task force of the
European association for the study of obesity for the post-bariatric surgery medical management. *Obesity Facts*, 10(6), 597-632.
Ciangura, C., Bouillot, J. L., Lloret-Linares, C., Poitou, C., Veyrie, N., Basdevant, A., & Oppert, J. M. (2010). Dynamics of change in total and regional body composition after gastric bypass in obese patients. *Obesity*, 18(4), 760-765.
Jacobsen, S. H., Olesen, S. C., Dirksen, C., Jørgensen, N. B., Bojsen-Møller, K. N., Kielgast, U., ... & Madsbad, S. (2012). Changes in gastrointestinal hormone responses, insulin sensitivity, and beta-cell function within 2 weeks after gastric bypass in non-diabetic subjects. *Obesity Surgery*, 22(7), 1084-1096.
Benaiges, D., Goday, A., Ramon, J. M., Hernandez, E., Pera, M., & Cano, J. F. (2011). Laparoscopic sleeve gastrectomy and laparoscopic gastric bypass are equally effective for reduction of cardiovascular risk in severely obese patients at one year of follow-up. *Surgery for Obesity and Related Diseases*, 7(5), 575-580.
Blüher, M. (2021). Obesity: Pathophysiology, Individualized Treatment and Pharmacotherapy. *Deutsches Ärzteblatt International*, 118(49), 840.
Vidal, J., & Jiménez, A. (2018). Potential Mechanisms of Metabolic Improvements After Bariatric Surgery. *Current Obesity Reports*, 7(4), 404-410.